Senate
Passed
2026 Regular Session

SR201

Log in to follow

A RESOLUTION encouraging Kentucky policymakers to study, develop, and implement economic development policies to incentivize biopharmaceutical investment and innovation in Kentucky.

Encourage Kentucky policymakers to study, develop, and implement economic development policies to incentivize biopharmaceutical investment and innovation in the Commonwealth.

Introduced: March 26, 2026

Last action: April 1, 2026

Adopted By Voice Vote
Read the full textKentucky LegislatureLegiScan
AI-generated — always verify with primary sources
Plain-language summary
Beta

This resolution encourages Kentucky policymakers to look into and create economic development policies aimed at attracting investment and growth in the biopharmaceutical industry within the state. It does not create new laws or programs on its own, but signals the Senate's support for exploring this direction. Biopharmaceuticals involve the development of medicines and treatments derived from biological sources. Who it may affect: Kentuckians working in or seeking jobs in the life sciences and pharmaceutical industries, as well as researchers and businesses in that sector.

Open official bill text (PDF)·Report a problem with the summary

Bill Text Versions

Introduced (original)

Most current
Read

Legislative History

Mar 26, 2026 · Senate
Introduced In Senate
Mar 26, 2026 · Senate
To Committee On Committees (S)
Mar 31, 2026 · Senate
To Senate Floor
Apr 1, 2026 · Senate
Adopted By Voice Vote

Primary Sponsor

Portrait of Shelley Frommeyer
Shelley Frommeyer

Senator · Senate District 24

Primary sponsor
shelley.funkefrommeyer@kylegislature.gov
BallotpediaOfficial profile

Co-sponsors (1)

Portrait of Robert Stivers
Robert Stivers

Senator · Senate District 25

Co-sponsor
Robert.Stivers@kylegislature.gov

Something wrong on this page? Tell us